who's who

3 Houston innovators to know this week

This week's roundup of Houston innovators includes Henal Patel of DocJuris, Patricia van Ee of Inhance Technologies, and Andrew Bruce of Data Gumbo. Courtesy photos

Editor's note: In the week's roundup of Houston innovators to know, I'm introducing you to three innovators across industries — plastics manufacturing, software, blockchain — recently making headlines.


Henal Patel, CEO of DocJuris

DocJuris has raised its first round of venture funding to grow its team to keep up with demand for its legal software platform. Photo courtesy of DocJuris

Henal Patel, CEO of Houston-based DocJuris, raised his first round of funding without ever having to move from behind his computer screen. The SaaS company founded in 2018 raised $3.2 million in seed funding led by New York-based RTP Seed with additional support from Houston-based Seed Round Capital along with others.

Patel says he was looking for funds as well as support from investors who had experience with software and could open doors to new clients for the legal software.

"Our platform is designed to empower legal, sales, and procurement teams and corporations to negotiate and close contracts with greater speed and precision," Patel says. "The underlying mission is to solve the last-mile of contracting." Click here to read more.

Patricia van Ee, chief commercial officer at Inhance Technologies

Houston-based sustainable plastics manufacturer Inhance Technologies has announced recent growth as business continues to boom. Photo via inhancetechnologies.com

Patricia van Ee has a new role at a growing Houston-based company. The new chief commercial officer at Inhance Technologies just assumed the position in January as the sustainable manufacturer, which transforms conventional plastics into high-performance materials, has opened its new 75,000-square-foot site in St. Louis.

"The expansion in St. Louis is a great moment for the company and a sign of the organization's ambition in sustainable solutions for plastics," van Ee says in a release. "We know consumers are favoring more recyclable plastics, especially in packaging … ." Click here to read more.

Andrew Bruce, CEO and founder of Data Gumbo

Data Gumbo, founded by Andrew Bruce, has launched a new tool for customers focused on transparency and ESG reporting. Photo courtesy of Data Gumbo

Last week, Data Gumbo, provider of GumboNet™, announced its new tool, GumboNet ESG, a sustainability measurement solution that can pull together a company's operational data to ESG standards reporting. The tool incorporates the Sustainability Accounting Standards Board framework for transparency and allows industrial companies access to real-time verifiable environmental performance monitoring.

"GumboNet ESG provides the ability to execute a company's monitoring of sustainability goals over time across their supply chain, providing trustworthy and auditable reports for the market against the credible and widely used SASB standards," says Andrew Bruce, founder and CEO of Data Gumbo, in a news release. "It's a new dawn for reliable and automated environmental impact measurements based on smart contracts powered and secured by blockchain."

Existing Data Gumbo customers will have access to the GumboNet ESG as part of their GumboNet subscription. All GumboNet ESG users can use the ESG tool to provide verified and transparent reporting to their customers, investors, media, and more. Click here to read more.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News